KRYSTAL BIOTECH INC
(NASDAQ: KRYS)

Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

164.040

-5.600 (-3.30%)
Range 163.450 - 171.455   (4.90%)
Open -
Previous Close 169.640
Bid Price 109.170
Bid Volume 14
Ask Price 118.920
Ask Volume 18
Volume 281,100
Value -
Remark
Delayed prices. Updated at 19 Apr 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis